Pharma News India
The company is looking at inorganic growth options in order to bolster its overseas presence.
New Delhi, October 29, 2014: With a view to increase its overseas presence, the Indian drug major Lupin is looking at acquisitions in the US, mainly in the inhalers and injectables segment. The company continues to evaluate opportunities and the acquisitions in the US with a view to ...
Breckenridge Pharmaceutical Inc, has received a tentative approval from the US health regulator for its generic Armodafinil tablets
New Delhi, October 21, 2014: Natco Pharma's marketing partner in the US, Breckenridge Pharmaceutical Inc, has received a tentative approval from the US health regulator for its generic Armodafinil tablets. These tablets are used for improving wakeful...
The growth is driven by the steady growth seen by the sector.
Mumbai, October 14, 2014: Pharmaceutical companies are expected to post a strong top line growth and improved profitability in the second quarter results of the current financial year. According to a report from Edelweiss Securities, it expects a robust growth of 18 per cent in revenues, EBITDA 22 per cent and earnings ...
The move is expected to boost its presence in a market worth US$ 4 billion.
Mumbai, October 7, 2014: The Indian drug firm Cipla has announced setting up of a plant in Iran as a part of its strategy to increase its presence in a market worth US$ 4 billion. The pharmaceutical market in Iran is growing at a rate of 13 per cent annually.
With the increasing reach in rural markets, the OTC market in India is set to rise.
New Delhi, October 6, 2014: The over the counter (OTC) drug market in India is expected to register robust growth with pharma companies and chemists increasing their presence in the rural parts of the country.